RxDoctor Payments Data

Pamela Egan

Family · Covington, LANPI 1700088788

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 365 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 56 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,553in general payments, 2019–2025

Across 365 payments — averaging $39.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • AbbVie$1K
  • Novo Nordisk$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$641
  • Amgen$492
  • Boehringer Ingelheim$399
  • plus $8K from 50 others

What the payments were for

  • Food & beverage$14,502100%
  • Education$410%
  • Gifts$100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)41$2,410
AbbVie38$1,454
Novo Nordisk41$1,328
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)13$641
Amgen4$492
Boehringer Ingelheim5$399
Gilead4$389
Bayer6$375
Lilly USA, LLC12$354
Amarin Pharma, Inc.17$324
Neurelis, Inc.3$319
Antares Pharma, Inc.17$319
QOL Medical, LLC11$316
Astellas Pharma US Inc10$311
Biohaven Pharmaceutical Holding Company Ltd.3$294
GSK6$290
Dexcom, Inc.2$255
Idorsia Pharmaceuticals US Inc14$253
Sanofi-aventis U.S. LLC3$242
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$227
Phathom Pharmaceuticals, Inc.2$215
Tolmar, Inc.9$189
Inspire Medical Systems, Inc.2$185
Ascend Therapeutics US, LLC19$159
Currax Pharmaceuticals LLC10$158
Esperion Therapeutics, Inc.3$155
Exact Sciences4$154
Daiichi Sankyo Inc.7$151
Abbott2$146
Edwards Lifesciences1$142
Intercept Pharmaceuticals, Inc.1$125
E.r. Squibb & Sons, L.L.C.1$125
Actelion Pharmaceuticals US, Inc.1$122
Johnson & Johnson1$115
Otsuka America Pharmaceutical, Inc.1$115
Teva Pharmaceuticals USA, Inc.1$107
Jazz Pharmaceuticals Inc.2$106
Biohaven Pharmaceuticals, Inc.1$100
Kiniksa Pharmaceuticals, Ltd.1$100
Merck1$97
Ardelyx, Inc.1$89
Pfizer4$85
Millicent US Inc5$76
Azurity Pharmaceuticals, Inc.4$68
Acella Pharmaceuticals, LLC4$68
Halozyme Inc3$61
Clarus Therapeutics Inc.5$57
Avion Pharmaceuticals3$51
Virtus Pharmaceuticals LLC4$49
Endo Pharmaceuticals Inc.2$38
Acerus Pharmaceuticals Corporation2$31
Alfasigma USA, Inc.2$31
Atland Pharmaceuticals, LLC1$30
Novartis1$23
Pharmacosmos Therapeutics Inc.1$21
Takeda Pharmaceuticals U.S.A., Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,553 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide106$115,723
TrulicityDulaglutide37$60,280
OzempicSemaglutide39$51,705
ProgesteroneProgesterone, Micronized411$18,175
XyostedTestosterone Enanthate31$17,676
Estradiol (Twice Weekly)Estradiol99$11,312
Estradiol (Once Weekly)Estradiol106$10,211
Armour ThyroidThyroid,pork93$7,607
DottiEstradiol58$7,153
Estradiol38$5,871
Liothyronine Sodium98$4,513
Np ThyroidThyroid,pork36$2,328
LyllanaEstradiol19$2,253
Testosterone Cypionate27$1,736
SynthroidLevothyroxine Sodium17$1,623

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$354$176,004143 claims
Novo NordiskOzempic$1,328$51,70539 claims
Antares Pharma, Inc.Xyosted$319$17,67631 claims
AbbVieArmour Thyroid, Synthroid$1,454$9,230110 claims
Acella Pharmaceuticals, LLCNp Thyroid$68$2,32836 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,610 family providers in Louisiana.

Other family in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →